JK
Jason Kolbert D. Boral Capital Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
51
UroGen Pharma
URGN
$991M
| $20.69 | $25 |
21%
upside
| Buy |
6 Nov ‘24
10 months ago |
|
52
VolitionRX
VNRX
$65.7M
| $0.6370 | $5 |
685%
upside
| Buy |
1 Nov ‘24
10 months ago |
|
53
Anavex Life Sciences
AVXL
$803M
| $10.26 | $46 |
348%
upside
| Buy |
31 Oct ‘24
10 months ago |
|
54
Biomea Fusion
BMEA
$108M
| $1.86 | $128 |
6,782%
upside
| Buy |
31 Oct ‘24
10 months ago |
|
55
Invivyd
IVVD
$243M
| $1.22 | $9 |
638%
upside
| Buy |
30 Oct ‘24
10 months ago |
|
56
NRX Pharmaceuticals
NRXP
$67.5M
| $3.15 | $31 |
884%
upside
| Buy |
30 Oct ‘24
10 months ago |
|
57
Humacyte
HUMA
$223M
| $1.50 | $25 |
1,567%
upside
| Buy |
28 Oct ‘24
10 months ago |
|
58
Clene
CLNN
$66.2M
| $6.60 | $23 |
248%
upside
| Buy |
24 Oct ‘24
10 months ago |
|
59
ImmunityBio
IBRX
$2.28B
| $2.57 | $30 |
1,067%
upside
| Buy |
23 Oct ‘24
10 months ago |
|
60
Quince Therapeutics
QNCX
$84.3M
| $1.61 | $12 |
645%
upside
| Buy |
22 Oct ‘24
10 months ago |
|
61
FibroBiologics
FBLG
$23.9M
| $0.5383 | $16 |
2,872%
upside
| Buy |
18 Oct ‘24
10 months ago |
|
62
Annovis Bio
ANVS
$45.8M
| $2.36 | $21 |
790%
upside
| Buy |
15 Oct ‘24
10 months ago |
|
|
KAPA
63
Kairos Pharma, Ltd.
KAPA
$38.4M
| $1.97 | $9 |
357%
upside
| Buy |
14 Oct ‘24
11 months ago |
|
|
CANF
64
Can-Fite BioPharma
CANF
$10.3M
| $0.6600 | $10 |
1,415%
upside
| Buy |
10 Oct ‘24
11 months ago |
|
|
OSTX
65
OS Therapies Incorporated
OSTX
$70.9M
| $2.19 | $21 |
859%
upside
| Buy |
3 Oct ‘24
11 months ago |
|
66
GeoVax Labs
GOVX
$17.7M
| $0.6890 | $18 |
2,512%
upside
| Buy |
2 Oct ‘24
11 months ago |
|
67
Artelo Biosciences
ARTL
$6.01M
| $4.68 | $36 |
669%
upside
| Buy |
1 Oct ‘24
11 months ago |
|
68
Anixa Biosciences
ANIX
$96M
| $2.98 | $10 |
236%
upside
| Buy |
30 Sep ‘24
11 months ago |
|
69
Enlivex Therapeutics
ENLV
$24.8M
| $1.03 | $13 |
1,162%
upside
| Buy |
26 Sep ‘24
11 months ago |
|
70
Reviva Pharmaceuticals
RVPH
$30.4M
| $0.4469 | $15 |
3,256%
upside
| Buy |
23 Sep ‘24
11 months ago |
|
71
Hoth Therapeutics
HOTH
$19.5M
| $1.46 | $5 |
242%
upside
| Buy |
5 Sep ‘24
1 year ago |
|
72
CollPlant Biotechnologies
CLGN
$33.6M
| $2.66 | $14 |
426%
upside
| Buy |
20 Aug ‘24
1 year ago |
|
73
Citius Pharmaceuticals
CTXR
$20.8M
| $1.21 | $150 |
12,297%
upside
| Buy |
19 Aug ‘24
1 year ago |
|
|
CTOR
74
Citius Oncology, Inc. Common Stock
CTOR
$144M
| $1.90 | $6 |
216%
upside
| Buy |
13 Aug ‘24
1 year ago |
|
75
Tonix Pharmaceuticals
TNXP
$222M
| $25.82 | $9,600 |
37,080%
upside
| Buy |
28 Feb ‘24
1 year ago |
|